“2023’s NYF Health Executive Jury are recognized for their exceptional reputation and world-renowned award-winning work,” said Scott Rose, President, New York Festivals Advertising Awards Competitions.
Featured Posts
The innovation gap: Why pharma is missing out on the latest advances in tech and data - The COVID-19 pandemic compelled the industry to re-examine the way it conducted clinical trials, engaged with patients, and promoted to HCPs. Companies began to explore decentralized clinical trials, new non-personal promotion strategies, virtual customer engagement strategies, and new ways to engage with the patient — all with an eye toward replacing status quo processes and technologies. The result was the accelerated development of new clinical and commercial technologies and data with the ultimate goal of bringing new therapies to patients faster.
Healthcare Agency Roundtable 2022: Tech trends, opportunities, and woes - Part III: Leaders in healthcare marketing and communications explain where technology will have the most impact on the industry. 
As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Fulling will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.
As the healthcare journey for patients living with cancer has changed, so has the way in which pharmaceutical companies bring a drug to market. Med Ad News spoke with Anne Marie Robertson, SVP, strategy & marketing, EVERSANA about how companies need to rethink traditional commercialization models in oncology to be agile in today’s market.
Dentsu today announced the appointment of Eduardo Tavares as Executive Creative Director, dentsu health. In this role, multi-award winner Tavares, will concept and deliver best-in-class creative campaigns – merging data and technology with craft – to drive value and competitive advantage for dentsu health clients across health & wellness and pharmaceutical sectors.
To effectively promote your brand, it is important to have a message that stands out and a story that will capture the attention of your target audience. We have utilized oncology message benchmarks to study more than 30,000 interactions between oncologists and sales representatives for over 100 brands to understand what could tick.
Although the pandemic gave a boost to the drug discovery market, accelerated development in the market will be influenced by effective use of data and analytics.
In his role, Reilly will continue to drive the rapid growth and innovation of health marketing services across dentsu.
In a filing in Manhattan federal court, the Federal Trade Commission said Shkreli has not complied with its requests for information relating to Druglike Inc., a company it said he formed last July, and noted his apparent failure to pay any of a $64.6 million penalty that accompanied the ban.
Price brings more than 25 years of experience in pharmaceutical marketing, extensive expertise across a wealth of therapy areas, and deep leadership experience in the EMEA and APAC regions.
Based in Tokyo, the new agency brings the storied FCB Health brand and it’s “never finished” spirit to the Japanese market – the world’s third largest pharmaceutical sector. The agency will harness and maximize the power of the global IPG Health network to continue delivering the best talent, capabilities, expertise, and customized solutions for clients in Japan.